Jamie Peck, Rosetta
Independence equals creativity, and solutions
Global holding companies are, in reality, nothing more than loose confederations of independent agencies, each with their own profit and loss statements (P&Ls) and profit goals. This can create multiple layers of unnecessary bureaucracy and overhead, actually resulting in increased cost to the client.
Jamie Peck
In a word, independence gives birth to creativity. Rosetta's point of view is that independent alliances, while sometimes hard to centrally manage, are the most effective way to serve our global clients creatively. For Allergan EMEA, Rosetta has acted as a sole provider of all digital solutions in 11 countries. This has resulted in several award-winning digital solutions, all managed centrally from the US.
By recognizing the inverse dynamic of emerging media in emerging regions, HC marketers can leverage the power of an entire arsenal of tools. Outside of the US, the Web is merely a portal or gateway for the patient and provider to access a myriad of other digitally enabled media outlets. By accessing these other channels (mobile, social, gaming, etc.), we are able to meet all of the targets' needs—emotional, educational, and value based—through the devices they rely on every day.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.
